Hypothermia combined with chemoradiotherapy in treatment of local advanced cervical cancer
10.3760/cma.j.jssn.1006-9801.2009.11.005
- VernacularTitle:热疗联合放化疗治疗局部晚期子宫颈癌的临床分析
- Author:
Xutong LI
;
Caixia ZHANG
;
Hongli YU
- Publication Type:Journal Article
- Keywords:
Uterine cervical neoplasms;
Drug therapy;
combination;
Radiotherapy;
Hyperthermia,induced
- From:
Cancer Research and Clinic
2009;21(11):734-736
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the efficacy and toxicity of hyperthermia combined with chemoradiotherapy for local advanced cervical cancer. Methods Sixty-eight patients with local advanced cervical cancer were treated. Each patient was given cisplatin at the dose of 20 mg ivgtt dl -2 and 5 -fluorouracil 0.75 ivgtt dl -2, repeating every week, total 3 weeks. Thirty -eight patients received chemoradiotherapy alone. Thirty patients received hyperthermia with deeply focus technology, the temperature was increased and maintained 42.5 ℃ for 30 min at least, within 2 hours following irridiation. Hyperthermia was given twice per week with 7 or 12 sessions, as the same chemoradiation methods as the reference group.After 40 Gy therapy to estimate by cervical examination and ultrasonography, the patients with down stage were for operation, and the others continued to irridiation and additional brachytherapy with californium 252until radical dose. Results All patients were tolerated, fifteen patients of hyperthermia combined group were operated and ten patients of the reference group were operated, the difference was significance (50.0 % vs.26.3 %, P <0.05). The response rate of the combined group was 90.0 %, and the reference group was 84.2 %.The incidence of radiotherapy toxicity of the combined group was not higher than the reference group.Conclusion Hyperthermia combined with chemoradiotherapy can elevate the resection rate and the local control rate, not increase the radiotherapy toxicity and increase quality of life for cervical cancer patients.
